The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
批准号:
10198768
负责人:
Chuanju Liu
金额:
$52.08万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2024-06-30
关键词:
AffinityAnkylosing spondylitisAnti-Inflammatory AgentsAntiinflammatory EffectAttentionBindingBiochemicalChronic small plaque psoriasisCollagen ArthritisComplement 5aComplexCrohn&aposs diseaseDependenceDevelopmentDiseaseDoseExhibitsFundingGenesGrowth FactorImmune responseImmunologicsInfectionInflammationInflammatoryInflammatory ArthritisInflammatory Bowel DiseasesInterventionKnock-outLaboratoriesLeadLigandsMass Spectrum AnalysisMediatingModelingMusPGRN genePathogenesisPathway interactionsPatientsPeptide FragmentsPhenotypePlayPositioning AttributeProcessProgress ReportsPropertyProteomicsPsoriatic ArthritisPublicationsRecombinantsRegulationRegulatory T-LymphocyteResearchRoleScienceSeriesSignal PathwaySignal TransductionSignaling MoleculeSystemic Lupus ErythematosusTNF geneTNFRSF1A geneTNFRSF1B geneTestingTherapeuticTransgenic OrganismsTumor Necrosis Factor ReceptorUlcerative Colitisbasebone erosioncancer riskchronic inflammatory diseaseclinical practicecomplement systemeffective therapyinhibitor/antagonistmacrophagemembernovelnovel therapeutic interventionpreventprogramsprotein protein interactionreceptorreceptor bindingrecruitresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Description
TNFα/TNFR has received the greatest attention because of its position at the apex of the pro-inflammatory cy-
tokine cascade, and its dominance in the pathogenesis of inflammation. TNFR1 primarily mediates inflammato-
ry activity of TNFα, whereas TNFR2 plays a protective and anti-inflammatory role in various diseases. Our ge-
netic screen for the binding partners of progranulin (PGRN) growth factor led to the isolation of TNFR2 as the
PGRN-binding receptor (Tang, et al, Science, 2011). Remarkably, PGRN exhibits an approximately 600-fold
higher binding affinity to TNFR2 than does TNFα. During the initial funding period, we have successfully identi-
fied in a proteomics screen 14-3-3ε, an important intracellular signaling molecule, as a novel component of
TNFR2 complexes in response to PGRN stimulation. PGRN deficiency promoted inflammatory classically-
activated macrophage (CAM) but inhibited anti-inflammatory alternatively-activated macrophage (AAM) polari-
zation, whereas recombinant PGRN inhibited AAM-CAM but stimulated CAM-AAM switching. In addition,
knockout of 14-3-3ε abolished PGRN’s regulation of macrophage. More excitingly, our direct protein-protein
interaction screen of nine central members of the complement system identified C5a as a novel binding partner
of PGRN with high binding affinity, and PGRN inhibited the binding of C5a to C5aR1. Thus, the scientific prem-
ise of this competitive continued application is based on 1) the identification of 14-3-3ε as a novel component
of PGRN/TNFR2 pathway, and 2) the isolation of C5a as a novel PGRN-binding factor. The central hypothesis
is that PGRN regulates macrophage polarization and inflammatory arthritis through a) recruitment of 14-3-3ε to
TNFR2 and activation of the PGRN/TNFR2 anti-inflammatory pathway; and b) interplay with C5a and inhibition
of C5a/C5aR1 inflammatory pathway. The Specific Aims are: (1) To elucidate 14-3-3ε’s role in PGRN/TNFR2-
mediated macrophage polarization in the course of inflammatory arthritis. We will determine the dependence
on 14-3-3ε of PGRN's regulation of macrophage polarization (SA#1.1); the signaling, target genes and co-
factor(s) of 14-3-3ε that mediate PGRN action in macrophage polarization (SA#1.2); and the importance of
PGRN regulation of macrophage phenotypic switch in the context of inflammatory arthritis and its dependence
on 14-3-3ε (SA#1.3). (2) To define the importance of PGRN/C5a interplay in the pathogenesis of inflammatory
arthritis. We will characterize and dissect the PGRN/C5a interaction and to identify PGRN-derived minimal
fragment/peptide that retains C5a binding activity (SA#2.1); elucidate the interplay between PGRN and C5a in
regulating macrophage polarization, as well as the signaling pathways involved (SA#2.2); and determine the
interplay between PGRN and C5a/C5aR1 signaling and the contribution of inhibition of C5a/C5aR1 signaling
by PGRN to PGRN's anti-inflammatory action in inflammatory arthritis (SA#2.3). The proposed research will
not only advance our understanding of the pathogenesis of inflammatory arthritis, but may also lead to the de-
velopment of new interventions for various TNFR- and C5a/C5aR1-related conditions and diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes
-
批准号:10915157
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2023
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:10912299
-
项目类别:
-
资助金额:$53.06万
-
财政年份:2023
-
负责人:Chuanju Liu
-
依托单位:
The Role of Sodium Channel Nav1.7 in Osteoarthritis - Resubmission - 1
-
批准号:10390155
-
项目类别:
-
资助金额:$69.54万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
A new mouse model to study GBA1 mutation-associated diseases with multiple organs involvement
-
批准号:10651885
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
A new mouse model to study GBA1 mutation-associated diseases with multiple organs involvement
-
批准号:10508985
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes - Resubmission - 1
-
批准号:10453563
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2020
-
负责人:Chuanju Liu
-
依托单位:
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes - Resubmission - 1
-
批准号:10218061
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2020
-
负责人:Chuanju Liu
-
依托单位:
Progranulin: A Novel Gene in Gaucher Diseases
-
批准号:10251862
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2017
-
负责人:Chuanju Liu
-
依托单位:
Progranulin: A Novel Gene in Gaucher Diseases
-
批准号:10011889
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2017
-
负责人:Chuanju Liu
-
依托单位:
Progranulin Intervention in Inflammatory Bowel Diseases
-
批准号:8708276
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8698896
-
项目类别:
-
资助金额:$47.49万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8698895
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8371576
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8509606
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8663197
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
Progranulin Intervention in Inflammatory Bowel Diseases
-
批准号:8534426
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
-
批准号:10431930
-
项目类别:
-
资助金额:$53.16万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8162691
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8707378
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1
-
批准号:9441625
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
海外基金